- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04280861
Multicomponent Intervention in Caregivers on Quality of Life of People With Dementia: a Clinical Trial
The main objective is to determine the effectiveness of a multicomponent intervention for caregivers, conducted by an expert psychologist to improve the quality of life of the people with Alzheimer's disease. Secondarily, will be analyzed the effectiveness of this program on improving anxiety and depressive symptoms, burden, happiness, social support and cognitive performance of the caregivers and alleviate the behavioural and psychological symptoms of dementia (BPSD). The investigators analyze the caregiver's and patient's personality as a possible moderator between dependent and independent variables, and the resources utilization before and after intervention.
Methods: randomized study with parallel assignment in two groups: control and intervention group, six-month follow-up. The eligible participants will be 94 adult (≥18 years) caregivers of patients with Alzheimer's disease who follow-up by Osona Integrated Geriatric Unite (Catalonia, Spain).
The intervention group will receive a multicomponent intervention that includes dementia psychoeducation and management, emotional and communication skills, mindfulness and healthy lifestyle. The control group will follow the standard management according to the primary and specialized care professionals' team.
Main measurements: quality of life of the patients at baseline, after intervention and at six-month follow-up through QoL-AD. Secondary measures: they will be determined, at baseline, after the intervention and at six-month follow-up: depression (HDRS) and anxiety (HARS), burden (CBI), happiness (OHQ), quality of life (QoL-AD), social support (UCLA and DUKE-ANC), cognitive performance (neuropsychological assessment) of the caregivers, resources utilization (RUD), BPSD (NPI), cognitive status (MMSE), functional status (IADL) of the patients. Caregiver's personality at baseline and six-month follow-up and dementia characteristics at baseline will be measured. Other measures: sociodemographic and health characteristics of the caregivers and patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jordina Muñoz Padrós, PhD Student
- Phone Number: 34-938520000
- Email: jmunoz@chv.cat
Study Contact Backup
- Name: Jordina Muñoz Padrós, PhD Student
- Phone Number: 34-398520000
- Email: jmunoz@chv.cat
Study Locations
-
-
Barcelona
-
Vic, Barcelona, Spain, 08500
- Recruiting
- Consorci Hospitalari de Vic
-
Contact:
- Jordina Muñoz Padrós, PhD Student
- Phone Number: 34-938520000
- Email: jmunoz@chv.cat
-
Principal Investigator:
- Jordina Muñoz Padrós, PhD Student
-
Sub-Investigator:
- Quintí Foguet Boreu, PhD
-
Sub-Investigator:
- Maite Garolera Freixa, PhD
-
Sub-Investigator:
- Anna Bartés Plans, Bachelor
-
Sub-Investigator:
- Yemila Plana, Master
-
Sub-Investigator:
- Èlia Pagespetit Feliu, Master
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adults (≥18 years of age)
- main caregivers of people with early or mild Alzheimer's disease
- follow-up by Osona Integrated Geriatric Unite (Catalonia)
- signed informed consent.
Exclusion Criteria:
- non stable medical condition the last six months (or any acute or chronic condition that would limit the ability of the patient to participate in the study)
- cognitive impairment (MMSE<24)
- substance abuse
- active psychotherapy
- refusal to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
The intervention group will participate in multicomponent intervention conducted by and expert psychologist that target different aspects of the caregiving experience (affective responses, communication skills, burden experience, social support and loneliness, cognitive performance, the practice of mindfulness and health-related behaviours).
The number of sessions will be 8, 1 session of 90 minutes a week, and the number of participants will be 12-14 per group.
In some sessions other collaborators will be invited to participate (social workers, physiotherapist).
|
Multicomponent intervention conducted by and expert psychologist that target different aspects of the caregiving experience (affective responses, communication skills, burden experience, social support and loneliness, cognitive performance, the practice of mindfulness and health-related behaviours).
The number of sessions will be 8, 1 session of 90 minutes a week, and the number of participants will be 12-14 per group.
In some sessions other collaborators will be invited to participate (social workers, physiotherapist).
Other Names:
|
NO_INTERVENTION: Control Group
Usual clinical care,
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in quality of life of the patients after intervention and 6 months follow-up in control and intervention group: Quality of Life-Alzheimer's Disease (QoL-AD)
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
Quality of life assessed using Quality of Life-Alzheimer's Disease (QoL-AD).
The total score ranges from 13 to 52, with a higher number indicating better quality of life
|
Baseline, immediately after the intervention and 6 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in quality of life of the caregivers: Quality of Life-Alzheimer's Disease (QoL-AD)
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
Quality of life assessed using Quality of Life-Alzheimer's Disease (QoL-AD).
The total score ranges from 13 to 52, with a higher number indicating better quality of life
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in loneliness
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
UCLA - University of California Loneliness Scale.
The total score ranges from 10 to 40.
Score: 20-30: moderate depression, and ≥ 20: severe loneliness
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in depression of the caregivers
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
HDRS: Hamilton Depression Rating Scale.
Score: 0-7: No depression; 8-13: Mild depression; 14-18: Moderate depression; 19-22: Severe depression and ≥ 23: Very severe depression
|
Baseline, immediately after the intervention and 6 month follow-up
|
Characteristics and changes in caregivers personality
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
NEO-Personality Inventory-R.
For each scale, the interval 20-35 indicates very low scores.
The interval 35-45 indicates low scores.
The interval 45-55 indicates average scores.
The interval 55-65 indicates high scores.
The interval 65-80 indicates very high scores.
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in cognitive performance of the caregivers
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
Neuropsychological assessment
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in sleep patterns of the caregivers
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
PSQI: Pittsburgh Sleep Quality Index.
The total score ranges from 0 to 21, with a higher number indicating better sleep quality
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes of the resource utilization
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
RUD: Resource Utilization in Dementia Questionnaire Scale
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in cognitive status of the patients
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
MMSE (Mini Mental State Examination).
Range scores 0 to 30.
Score: 24-30: no cognitive impairment; 19-23: mild cognitive impairment; 10-18: moderate cognitive impairment; ≤9: severe cognitive impairment
|
Baseline, immediately after the intervention and 6 month follow-up
|
Changes in Behavioural and Psychological Symptoms of Dementia
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
NeuroPsychiatric Inventory.
12 scales, the domain total score is the product of the frequency score multiplied by the severity score for that behavioral domain
|
Baseline, immediately after the intervention and 6 month follow-up
|
Satisfaction with the intervention: Interview
Time Frame: Immediately after the intervention
|
Satisfaction Interview
|
Immediately after the intervention
|
Changes in perceived social support of the caregivers
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
DUKE-ANC.
The total score ranges from 11 to 55, with a higher number indicating worse perceibed social support
|
Baseline, immediately after the intervention and 6 month follow-up
|
Anxiety
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
HARS- Hamilton Anxiety Rating Scale.
Score: 0-5: No anxiety; 6-14: Mild anxiety; ≥ 15: Moderate to severe anxiety
|
Baseline, immediately after the intervention and 6 month follow-up
|
Happiness
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
OHQ : Oxford Happiness Questionnaire.
The total score ranges from 8 to 54, with a higher number indicating better subjective wellness
|
Baseline, immediately after the intervention and 6 month follow-up
|
Burden in caregivers
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
CBI: Caregiver Burden Interview.
Total score ranges from 22 to 110.
Score: 22-46: No burden; 47-55: burden; 56-110: intense burden
|
Baseline, immediately after the intervention and 6 month follow-up
|
Functional status of the patients
Time Frame: Baseline, immediately after the intervention and 6 month follow-up
|
IADL: Instrumental.
Activities of Daily Living.
Sum the binary responses of each activity, sum the eight responses The higher the score, the greater the person's abilities
|
Baseline, immediately after the intervention and 6 month follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AC278
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on Multicomponent Intervention
-
Duke-NUS Graduate Medical SchoolCompleted
-
Servicio Canario de SaludInstituto de Salud Carlos IIICompletedSystemic Lupus ErythematosusSpain
-
Hospital Universitario GetafeKarolinska Institutet; Medical University of Lodz; Universidad Politecnica de... and other collaboratorsUnknownFrail Elderly Syndrome | Frailty | Frailty SyndromePoland, Spain, Sweden
-
University Rovira i VirgiliDiputació de TarragonaCompletedDiet Modification | Food Preferences | Diet Habit | Food Allergy | Food Intolerance | InterventionSpain
-
University of PittsburghHealth Resources and Services Administration (HRSA)Completed
-
Duke-NUS Graduate Medical SchoolRecruitingChronic Kidney DiseasesSingapore
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative... and other collaboratorsCompletedKidney Diseases | End Stage Renal Disease | Kidney FailureCanada
-
Geisinger ClinicRecruiting
-
Centro de Estudio de Estado y SociedadDana-Farber Cancer Institute; Deakin UniversityCompleted
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain